Associations between mercury levels in urine and allergic diseases in children.
Boundless Bio raises $100m as IPO market rouses – Pharmaceutical Technology
Share this article The IPO market is rebounding, with several pharma companies already listing this year. Image credit: Shutterstock/kenary820. US-based Boundless Bio will offer 6,250,000